[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

VPAResearch: Market Research Reports

VPA Research is one of the global pharmaceutical companies specialized in analysis of clinical trials. We provide leading insights into global Pharma products, pipeline research, companies and drugs markets.

Publications found: 58,333
Sort by:

Global Hypertrophic Cardiomyopathy Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,619.00

... Hypertrophic Cardiomyopathy condition and increased access to investments is encouraging growth of Hypertrophic Cardiomyopathy drug pipeline. However, despite high levels of pipeline ... clear and actionable insights into Hypertrophic Cardiomyopathy drug pipeline for companies to optimize spending levels by ...

August 2019 47 pages

Global Hypoparathyroidism Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,619.00

... structured to provide clear and actionable insights into Hypoparathyroidism drug pipeline for companies to optimize spending levels by understanding competition, ... at each stage to evaluate trends, analysis and forecasts. Scope of the Research Hypoparathyroidism Pipeline candidates- Pre-clinical Phase: Discovery ...

August 2019 50 pages

Global Hypotension Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,619.00

... structured to provide clear and actionable insights into Hypotension drug pipeline for companies to optimize spending levels by understanding competition, ... checks at each stage to evaluate trends, analysis and forecasts. Scope of the Research Hypotension Pipeline candidates- Pre-clinical Phase: Discovery, ...

August 2019 45 pages

Global Hypothyroidism Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,619.00

... structured to provide clear and actionable insights into Hypothyroidism drug pipeline for companies to optimize spending levels by understanding competition, ... checks at each stage to evaluate trends, analysis and forecasts. Scope of the Research Hypothyroidism Pipeline candidates- Pre-clinical Phase: Discovery, ...

August 2019 45 pages

Global Insomnia Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,619.00

... is structured to provide clear and actionable insights into Insomnia drug pipeline for companies to optimize spending levels by understanding competition, their ... checks at each stage to evaluate trends, analysis and forecasts. Scope of the Research Insomnia Pipeline candidates- Pre-clinical Phase: Discovery, ...

August 2019 101 pages

Global Keloids Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,619.00

... is structured to provide clear and actionable insights into Keloids drug pipeline for companies to optimize spending levels by understanding competition, their ... checks at each stage to evaluate trends, analysis and forecasts. Scope of the Research Keloids Pipeline candidates- Pre-clinical Phase: Discovery, ...

August 2019 45 pages

Global Left Ventricular Dysfunction Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,619.00

... 2 Left Ventricular Dysfunction drugs Late phase: Phase 3 and in-approval Left Ventricular Dysfunction drugs Companies involved in the Pipeline- Company overview Snapshot Left Ventricular Dysfunction therapeutic treatment activities Details for each Left Ventricular Dysfunction drug ...

August 2019 47 pages

Global Low Back Pain Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,619.00

... 2 Low Back Pain drugs Late phase: Phase 3 and in-approval Low Back Pain drugs Companies involved in the Pipeline- Company overview Snapshot Low Back Pain therapeutic treatment activities Details for each Low Back Pain drug ...

August 2019 103 pages

Global Meniere Disease Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,619.00

... causes of Meniere Disease condition and increased access to investments is encouraging growth of Meniere Disease drug pipeline. However, despite high levels of pipeline activity, ... to provide clear and actionable insights into Meniere Disease drug pipeline for companies to optimize spending levels by understanding ...

August 2019 45 pages

Global Metachromatic Leukodystrophy Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,619.00

... Metachromatic Leukodystrophy condition and increased access to investments is encouraging growth of Metachromatic Leukodystrophy drug pipeline. However, despite high levels of pipeline ... clear and actionable insights into Metachromatic Leukodystrophy drug pipeline for companies to optimize spending levels by ...

August 2019 43 pages

Global Microscopic Polyangiitis (MPA) Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,619.00

... 2 Microscopic Polyangiitis (MPA) drugs Late phase: Phase 3 and in-approval Microscopic Polyangiitis (MPA) drugs Companies involved in the Pipeline- Company overview Snapshot Microscopic Polyangiitis (MPA) therapeutic treatment activities Details for each Microscopic Polyangiitis (MPA) drug ...

August 2019 47 pages

Global Mild Cognitive Impairment Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,619.00

... 2 Mild Cognitive Impairment drugs Late phase: Phase 3 and in-approval Mild Cognitive Impairment drugs Companies involved in the Pipeline- Company overview Snapshot Mild Cognitive Impairment therapeutic treatment activities Details for each Mild Cognitive Impairment drug ...

August 2019 86 pages

Global Multiple System Atrophy (Shy-Drager Syndrome) Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,619.00

... in-approval Multiple System Atrophy (Shy-Drager Syndrome) drugs Companies involved in the Pipeline- Company overview Snapshot Multiple System Atrophy (Shy-Drager Syndrome) therapeutic treatment activities Details for each Multiple System Atrophy (Shy-Drager Syndrome ...

August 2019 60 pages

Global Myocardial Fibrosis Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,619.00

... of Myocardial Fibrosis condition and increased access to investments is encouraging growth of Myocardial Fibrosis drug pipeline. However, despite high levels of pipeline activity, ... to provide clear and actionable insights into Myocardial Fibrosis drug pipeline for companies to optimize spending levels by understanding ...

August 2019 73 pages

Global Myocarditis Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,619.00

... structured to provide clear and actionable insights into Myocarditis drug pipeline for companies to optimize spending levels by understanding competition, ... checks at each stage to evaluate trends, analysis and forecasts. Scope of the Research Myocarditis Pipeline candidates- Pre-clinical Phase: Discovery, ...

August 2019 40 pages

Global Narcolepsy Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,619.00

... structured to provide clear and actionable insights into Narcolepsy drug pipeline for companies to optimize spending levels by understanding competition, their ... checks at each stage to evaluate trends, analysis and forecasts. Scope of the Research Narcolepsy Pipeline candidates- Pre-clinical Phase: Discovery, ...

August 2019 81 pages

Global Nasal Polyps Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,619.00

... causes of Nasal Polyps condition and increased access to investments is encouraging growth of Nasal Polyps drug pipeline. However, despite high levels of pipeline activity, increasing ... to provide clear and actionable insights into Nasal Polyps drug pipeline for companies to optimize spending levels by understanding competition ...

August 2019 50 pages

Global Nasopharyngitis (Common Cold) Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,619.00

... 2 Nasopharyngitis (Common Cold) drugs Late phase: Phase 3 and in-approval Nasopharyngitis (Common Cold) drugs Companies involved in the Pipeline- Company overview Snapshot Nasopharyngitis (Common Cold) therapeutic treatment activities Details for each Nasopharyngitis (Common Cold) drug ...

August 2019 49 pages

Global Neuromyelitis Optica (Devic’s Syndrome) Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,619.00

... 3 and in-approval Neuromyelitis Optica (Devic’s Syndrome) drugs Companies involved in the Pipeline- Company overview Snapshot Neuromyelitis Optica (Devic’s Syndrome) therapeutic treatment activities Details for each Neuromyelitis Optica (Devic’s Syndrome) drug candidate ...

August 2019 86 pages

Global Nicotine Addiction Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,619.00

... of Nicotine Addiction condition and increased access to investments is encouraging growth of Nicotine Addiction drug pipeline. However, despite high levels of pipeline activity, ... to provide clear and actionable insights into Nicotine Addiction drug pipeline for companies to optimize spending levels by understanding ...

August 2019 70 pages

Global Obsessive-Compulsive Disorder Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,619.00

... understanding of underlying causes of Obsessive-Compulsive Disorder condition and increased access to investments is encouraging growth of Obsessive-Compulsive Disorder drug pipeline. However, despite high levels of pipeline activity, increasing clinical trial ...

August 2019 45 pages

Global Onychomycosis Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,619.00

... structured to provide clear and actionable insights into Onychomycosis drug pipeline for companies to optimize spending levels by understanding competition, ... checks at each stage to evaluate trends, analysis and forecasts. Scope of the Research Onychomycosis Pipeline candidates- Pre-clinical Phase: Discovery, ...

August 2019 59 pages

Global Opioid (Opium) Addiction Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,619.00

... 2 Opioid (Opium) Addiction drugs Late phase: Phase 3 and in-approval Opioid (Opium) Addiction drugs Companies involved in the Pipeline- Company overview Snapshot Opioid (Opium) Addiction therapeutic treatment activities Details for each Opioid (Opium) Addiction drug ...

August 2019 95 pages

Global Otitis Media Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,619.00

... causes of Otitis Media condition and increased access to investments is encouraging growth of Otitis Media drug pipeline. However, despite high levels of pipeline activity, increasing ... to provide clear and actionable insights into Otitis Media drug pipeline for companies to optimize spending levels by understanding competition ...

August 2019 49 pages

Global Painful Bladder Syndrome (Interstitial Cystitis) Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,619.00

... in-approval Painful Bladder Syndrome (Interstitial Cystitis) drugs Companies involved in the Pipeline- Company overview Snapshot Painful Bladder Syndrome (Interstitial Cystitis) therapeutic treatment activities Details for each Painful Bladder Syndrome (Interstitial Cystitis ...

August 2019 56 pages

Global Periodontitis Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,619.00

... structured to provide clear and actionable insights into Periodontitis drug pipeline for companies to optimize spending levels by understanding competition, ... checks at each stage to evaluate trends, analysis and forecasts. Scope of the Research Periodontitis Pipeline candidates- Pre-clinical Phase: Discovery, ...

August 2019 55 pages

Global Peripheral Arterial Disease (PAD) Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,619.00

... 3 and in-approval Peripheral Arterial Disease (PAD) drugs Companies involved in the Pipeline- Company overview Snapshot Peripheral Arterial Disease (PAD) therapeutic treatment activities Details for each Peripheral Arterial Disease (PAD) drug candidate ...

August 2019 130 pages

Global Peripheral Vascular Disease (PVD) Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,619.00

... 3 and in-approval Peripheral Vascular Disease (PVD) drugs Companies involved in the Pipeline- Company overview Snapshot Peripheral Vascular Disease (PVD) therapeutic treatment activities Details for each Peripheral Vascular Disease (PVD) drug candidate ...

August 2019 130 pages

Global Plague Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,619.00

... is structured to provide clear and actionable insights into Plague drug pipeline for companies to optimize spending levels by understanding competition, their ... checks at each stage to evaluate trends, analysis and forecasts. Scope of the Research Plague Pipeline candidates- Pre-clinical Phase: Discovery, ...

August 2019 51 pages

Global Post-Traumatic Stress Disorder (PTSD) Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,619.00

... 3 and in-approval Post-Traumatic Stress Disorder (PTSD) drugs Companies involved in the Pipeline- Company overview Snapshot Post-Traumatic Stress Disorder (PTSD) therapeutic treatment activities Details for each Post-Traumatic Stress Disorder (PTSD) drug candidate ...

August 2019 112 pages

Global Pressure Ulcers Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,619.00

... causes of Pressure Ulcers condition and increased access to investments is encouraging growth of Pressure Ulcers drug pipeline. However, despite high levels of pipeline activity, ... to provide clear and actionable insights into Pressure Ulcers drug pipeline for companies to optimize spending levels by understanding ...

August 2019 45 pages

Global Progressive Supranuclear Palsy Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,619.00

... 2 Progressive Supranuclear Palsy drugs Late phase: Phase 3 and in-approval Progressive Supranuclear Palsy drugs Companies involved in the Pipeline- Company overview Snapshot Progressive Supranuclear Palsy therapeutic treatment activities Details for each Progressive Supranuclear Palsy drug ...

August 2019 78 pages

Global Pruritus Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,619.00

... is structured to provide clear and actionable insights into Pruritus drug pipeline for companies to optimize spending levels by understanding competition, their ... checks at each stage to evaluate trends, analysis and forecasts. Scope of the Research Pruritus Pipeline candidates- Pre-clinical Phase: Discovery, ...

August 2019 121 pages

Global Pulmonary Embolism Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,619.00

... of Pulmonary Embolism condition and increased access to investments is encouraging growth of Pulmonary Embolism drug pipeline. However, despite high levels of pipeline activity, ... to provide clear and actionable insights into Pulmonary Embolism drug pipeline for companies to optimize spending levels by understanding ...

August 2019 45 pages

Global Raynauds Disease Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,619.00

... causes of Raynauds Disease condition and increased access to investments is encouraging growth of Raynauds Disease drug pipeline. However, despite high levels of pipeline activity, ... to provide clear and actionable insights into Raynauds Disease drug pipeline for companies to optimize spending levels by understanding ...

August 2019 40 pages

Global Restenosis Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,619.00

... structured to provide clear and actionable insights into Restenosis drug pipeline for companies to optimize spending levels by understanding competition, their ... checks at each stage to evaluate trends, analysis and forecasts. Scope of the Research Restenosis Pipeline candidates- Pre-clinical Phase: Discovery, ...

August 2019 35 pages

Global Restless Legs Syndrome Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,619.00

... 2 Restless Legs Syndrome drugs Late phase: Phase 3 and in-approval Restless Legs Syndrome drugs Companies involved in the Pipeline- Company overview Snapshot Restless Legs Syndrome therapeutic treatment activities Details for each Restless Legs Syndrome drug ...

August 2019 52 pages

Global Rett Syndrome Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,619.00

... causes of Rett Syndrome condition and increased access to investments is encouraging growth of Rett Syndrome drug pipeline. However, despite high levels of pipeline activity, ... to provide clear and actionable insights into Rett Syndrome drug pipeline for companies to optimize spending levels by understanding ...

August 2019 89 pages

Global Rosacea Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,619.00

... is structured to provide clear and actionable insights into Rosacea drug pipeline for companies to optimize spending levels by understanding competition, their ... checks at each stage to evaluate trends, analysis and forecasts. Scope of the Research Rosacea Pipeline candidates- Pre-clinical Phase: Discovery, ...

August 2019 82 pages

Global Scar Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,619.00

... made in accelerating compounds into advanced stages. However, fluctuating trends are being observed in average duration across three phases. Increased ... is structured to provide clear and actionable insights into Scar drug pipeline for companies to optimize spending levels by understanding competition, their ...

August 2019 70 pages

Global Secondary Hyperparathyroidism Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,619.00

... understanding of underlying causes of Secondary Hyperparathyroidism condition and increased access to investments is encouraging growth of Secondary Hyperparathyroidism drug pipeline. However, despite high levels of pipeline activity, increasing clinical trial ...

August 2019 50 pages

Global Sedation Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,619.00

... is structured to provide clear and actionable insights into Sedation drug pipeline for companies to optimize spending levels by understanding competition, their ... checks at each stage to evaluate trends, analysis and forecasts. Scope of the Research Sedation Pipeline candidates- Pre-clinical Phase: Discovery, ...

August 2019 45 pages

Global Sinusitis (Rhinosinusitis) Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,619.00

... Sinusitis (Rhinosinusitis) condition and increased access to investments is encouraging growth of Sinusitis (Rhinosinusitis) drug pipeline. However, despite high levels of pipeline ... provide clear and actionable insights into Sinusitis (Rhinosinusitis) drug pipeline for companies to optimize spending levels by ...

August 2019 78 pages

Global Spinal Muscular Atrophy (SMA) Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,619.00

... 3 and in-approval Spinal Muscular Atrophy (SMA) drugs Companies involved in the Pipeline- Company overview Snapshot Spinal Muscular Atrophy (SMA) therapeutic treatment activities Details for each Spinal Muscular Atrophy (SMA) drug candidate ...

August 2019 101 pages

Global Thromboembolism Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,619.00

... structured to provide clear and actionable insights into Thromboembolism drug pipeline for companies to optimize spending levels by understanding competition, ... checks at each stage to evaluate trends, analysis and forecasts. Scope of the Research Thromboembolism Pipeline candidates- Pre-clinical Phase: Discovery, ...

August 2019 73 pages

Global Tinnitus Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,619.00

... is structured to provide clear and actionable insights into Tinnitus drug pipeline for companies to optimize spending levels by understanding competition, their ... checks at each stage to evaluate trends, analysis and forecasts. Scope of the Research Tinnitus Pipeline candidates- Pre-clinical Phase: Discovery, ...

August 2019 54 pages

Global Tourette syndrome Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,619.00

... causes of Tourette syndrome condition and increased access to investments is encouraging growth of Tourette syndrome drug pipeline. However, despite high levels of pipeline activity, ... to provide clear and actionable insights into Tourette syndrome drug pipeline for companies to optimize spending levels by understanding ...

August 2019 51 pages

Global Trigeminal Neuralgia Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,619.00

... of Trigeminal Neuralgia condition and increased access to investments is encouraging growth of Trigeminal Neuralgia drug pipeline. However, despite high levels of pipeline activity, ... provide clear and actionable insights into Trigeminal Neuralgia drug pipeline for companies to optimize spending levels by understanding ...

August 2019 50 pages

Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,619.00

... bio Inc, Global Blood Therapeutics Inc, Hillhurst Biopharmaceuticals Inc, Imara Inc and others. A Significant contribution to the Vaso-Occlusive Crisis Associated With Sickle Cell Disease ...

August 2019 60 pages

Global Venous Leg Ulcers Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,619.00

... 2 Venous Leg Ulcers drugs Late phase: Phase 3 and in-approval Venous Leg Ulcers drugs Companies involved in the Pipeline- Company overview Snapshot Venous Leg Ulcers therapeutic treatment activities Details for each Venous Leg Ulcers drug ...

August 2019 57 pages

Filters

Search

Categories

60
12,968
1,223
4,429
2
1
10,890
2,818
15,138
67
8,921
1
1,229
586

Publishers

58,333

Regions

1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
58,296

Price

Date

Pages

Offers